Fund Manager Christy Mathai sees easing war-driven inflation fears, expecting a shorter earnings hit. He's selectively adding to his portfo...

Bank of Baroda has broken out of a consolidation range with bullish technical indicators, including a weekly bullish engulfing pattern and ...

Approximately $26 billion in shares from 71 recently listed companies will become available for sale as IPO lock-ins expire between June 17...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...

Global drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...

A US district court dismissed patent infringement claims against Hexaware Technologies, ruling that Natsoft Corporation's asserted patents ...

Jio Platforms has surged into the global top 20 of WIPO's PCT rankings, a remarkable leap of 320 positions. This achievement highlights Jio...

European shares surged on Friday, driven by renewed hopes for a Middle East diplomatic breakthrough that lowered oil prices. The pan-Europe...

India's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...

The benchmark snapped a four-day losing streak on Thursday, as ⁠investors digested the European Central Bank's rate hike and largely looked...

Britain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...

Danish drugmaker Novo Nordisk has confirmed a security incident. Unauthorised access to internal IT systems occurred. Certain non-public da...

India's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...

Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...

Eli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...

Novo Holdings is investing 500 million euros in the new Scaleup Europe Fund. This pan-European fund aims to support technology companies th...

Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...